|
|
Name: |
Checkpoint Capital L.P. |
City: |
SAN FRANCISCO |
State: |
CA |
Zip: |
94111 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
ARGX |
Argenx Se |
1 |
- |
$543.48 |
$68,064,000 |
115,000 |
37.34% |
11,176,000 |
22,500 |
0.245 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
2 |
- |
$65.77 |
$48,057,000 |
907,240 |
26.37% |
7,305,000 |
179,258 |
1.279 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
3 |
- |
$37.87 |
$13,862,000 |
392,011 |
7.61% |
4,677,000 |
182,011 |
0.231 |
N/A |
|
SLNO |
Soleno Therapeutics Inc |
4 |
- |
$0.16 |
$12,354,000 |
172,902 |
6.78% |
9,206,000 |
102,875 |
0.217 |
N/A |
|
IRON |
Disc Medicine, Inc |
5 |
- |
$54.75 |
$12,078,000 |
243,311 |
6.63% |
349,000 |
58,311 |
0.818 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
6 |
- |
$51.05 |
$8,472,000 |
175,184 |
4.65% |
8,472,000 |
175,184 |
0.274 |
N/A |
|
STOK |
Stoke Therapeutics, Inc. |
7 |
- |
$11.48 |
$4,859,000 |
730,717 |
2.67% |
1,491,000 |
425,330 |
1.166 |
N/A |
|
SEPN |
Septerna, Inc. |
8 |
New |
$11.37 |
$4,776,000 |
824,878 |
2.62% |
4,776,000 |
824,878 |
1.858 |
N/A |
|
KYMR |
Kymera Therapeutics, Inc. |
9 |
- |
$0.00 |
$3,739,000 |
136,605 |
2.05% |
620,000 |
59,070 |
0.193 |
N/A |
|
TCRX |
Tscan Therapeutics, Inc. |
10 |
- |
$0.00 |
$2,784,000 |
2,017,650 |
1.53% |
-2,554,000 |
261,663 |
4.633 |
N/A |
|
CDTX |
Cidara Therapeutics, Inc. |
11 |
- |
$48.78 |
$2,248,000 |
104,380 |
1.23% |
-2,866,000 |
-92,569 |
2.289 |
N/A |
|
CORT |
Corcept Therapeutics Inc |
12 |
New |
$72.27 |
$571,000 |
5,000 |
0.31% |
571,000 |
5,000 |
0.004 |
Biotechnology |
|
IMCR |
Immunocore Holdings Adr |
13 |
New |
$33.02 |
$267,000 |
9,011 |
0.15% |
267,000 |
9,011 |
0.018 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
14 |
New |
$1.03 |
$134,000 |
109,830 |
0.07% |
134,000 |
109,830 |
0.304 |
N/A |
|
AVDL |
AVADEL Pharmaceuticals Plc |
17 |
Closed |
$15.99 |
$0 |
0 |
0% |
-10,560,000 |
-1,004,790 |
0 |
Drug Delivery |
|
CYTK |
Cytokinetics Inc |
16 |
Closed |
$34.66 |
$0 |
0 |
0% |
-941,000 |
-20,000 |
0 |
Biotechnology |
|
AXSM |
Axsome Therapeutics, Inc. |
15 |
Closed |
$105.44 |
$0 |
0 |
0% |
-14,787,000 |
-174,769 |
0 |
N/A |
|
PLRX |
Pliant Therapeutics, Inc. |
21 |
Closed |
$0.00 |
$0 |
0 |
0% |
-7,052,000 |
-535,494 |
0 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
20 |
Closed |
$0.00 |
$0 |
0 |
0% |
-18,466,000 |
-2,274,157 |
0 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
19 |
Closed |
$0.00 |
$0 |
0 |
0% |
-4,467,000 |
-1,084,135 |
0 |
N/A |
|
LIFE |
aTyr Pharma Inc |
18 |
Closed |
$0.37 |
$0 |
0 |
0% |
-1,566,000 |
-432,561 |
0 |
N/A |
|